What did CVS Health Corporation pay for EntrustRx Specialty Pharmacy?

CVS Health Corporation acquired EntrustRx Specialty Pharmacy for $43.8M in 2018, equivalent to 0.20x revenue. Target revenue was approximately $275.9M.

What does EntrustRx Specialty Pharmacy do?

EntrustRx Specialty Pharmacy is a pharmacy business.

What multiple did CVS Health Corporation pay for EntrustRx Specialty Pharmacy?

0.20x revenue, based on disclosed deal value of $43.8M and disclosed financials.

M&A TRANSACTION · 2018

EntrustRx Specialty Pharmacy acquired by CVS Health Corporation

$43.8M· 0.20x revenue

Target

EntrustRx Specialty Pharmacy

Acquirer

CVS Health Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$275.9M

EBITDA

—

Deal Value

$43.8M

EV/EBITDA

—

Context

This $43.8M acquisition of EntrustRx Specialty Pharmacy by CVS Health Corporation sits in the pharmacy sub-vertical. CVS Health Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price pharmacy businesses on our Pharmacy strategic buyer-pool page.

Source

Data sourced from Press releases and SEC filings. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own pharmacy

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the EntrustRx Specialty Pharmacy acquisition.

Citation: ExitValue.ai. (2018). EntrustRx Specialty Pharmacy acquired by CVS Health Corporation. https://exitvalue.ai/deals/entrustrx-specialty-pharmacy-acquired-by-cvs-health-corporation-hc-2018-0171